Blue Jean Financial LLC Purchases New Position in Cognex Corporation $CGNX

Blue Jean Financial LLC purchased a new stake in Cognex Corporation (NASDAQ:CGNX) in the fourth quarter, HoldingsChannel reports. The fund purchased 53,739 shares of the scientific and technical instruments company’s stock, valued at approximately $1,934,000. Cognex comprises about 1.6% of Blue Jean Financial LLC’s investment portfolio, making the stock its 18th biggest position.

Other institutional investors have also added to or reduced their stakes in the company. CIBC Private Wealth Group LLC lifted its stake in Cognex by 74.8% in the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after purchasing an additional 327 shares during the last quarter. Geneos Wealth Management Inc. raised its stake in shares of Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after acquiring an additional 736 shares in the last quarter. Smartleaf Asset Management LLC increased its holdings in Cognex by 207.6% during the third quarter. Smartleaf Asset Management LLC now owns 935 shares of the scientific and technical instruments company’s stock valued at $43,000 after buying an additional 631 shares during the period. Rothschild Investment LLC increased its holdings in Cognex by 21,060.0% during the third quarter. Rothschild Investment LLC now owns 1,058 shares of the scientific and technical instruments company’s stock valued at $48,000 after buying an additional 1,053 shares during the period. Finally, Caitong International Asset Management Co. Ltd purchased a new position in Cognex during the fourth quarter valued at approximately $39,000. Institutional investors own 88.12% of the company’s stock.

Insiders Place Their Bets

In other Cognex news, VP Darren Marc Long sold 20,252 shares of the stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the sale, the vice president directly owned 3,990 shares in the company, valued at $264,696.60. This represents a 83.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Laura Ann Macdonald sold 41,600 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $65.56, for a total transaction of $2,727,296.00. Following the sale, the vice president owned 5,258 shares in the company, valued at approximately $344,714.48. This trade represents a 88.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 224,847 shares of company stock worth $14,975,098 in the last ninety days. 1.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have issued reports on CGNX shares. UBS Group set a $75.00 price target on shares of Cognex in a report on Tuesday, May 26th. Sanford C. Bernstein reiterated an “outperform” rating and set a $75.00 price objective on shares of Cognex in a research note on Thursday, May 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cognex in a report on Friday, May 15th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $80.00 price target (up from $70.00) on shares of Cognex in a report on Monday, May 11th. Finally, DA Davidson set a $62.00 price objective on shares of Cognex and gave the stock a “neutral” rating in a research report on Thursday, May 14th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $70.43.

Cognex Price Performance

Cognex stock opened at $63.61 on Friday. The firm has a 50 day simple moving average of $59.69 and a 200-day simple moving average of $49.35. Cognex Corporation has a 1-year low of $29.22 and a 1-year high of $71.90. The stock has a market cap of $10.59 billion, a price-to-earnings ratio of 75.73 and a beta of 1.52.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.25 by $0.09. The firm had revenue of $268.44 million during the quarter, compared to analysts’ expectations of $245.98 million. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The firm’s quarterly revenue was up 24.3% on a year-over-year basis. During the same quarter last year, the company posted $0.14 EPS. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Equities analysts expect that Cognex Corporation will post 1.41 earnings per share for the current fiscal year.

Cognex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 4th. Shareholders of record on Thursday, May 21st were issued a dividend of $0.085 per share. The ex-dividend date was Thursday, May 21st. This represents a $0.34 dividend on an annualized basis and a yield of 0.5%. Cognex’s dividend payout ratio is 40.48%.

About Cognex

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.